197 related articles for article (PubMed ID: 15711755)
21. Activation of the plasma kallikrein/kinin system on endothelial cells.
Rojkjaer R; Schmaier AH
Proc Assoc Am Physicians; 1999; 111(3):220-7. PubMed ID: 10354362
[TBL] [Abstract][Full Text] [Related]
22. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
Schousboe I; Halkier T
Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
[TBL] [Abstract][Full Text] [Related]
23. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
24. The levels of factor XIIa generated in human plasma on an electronegative surface are insensitive to wide variation in the concentration of FXII, prekallikrein, high molecular weight kininogen or FXI.
Mitropoulos KA
Thromb Haemost; 1999 Sep; 82(3):1033-40. PubMed ID: 10494760
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.
Taylor SL; Wahl-Jensen V; Copeland AM; Jahrling PB; Schmaljohn CS
PLoS Pathog; 2013; 9(7):e1003470. PubMed ID: 23874198
[TBL] [Abstract][Full Text] [Related]
26. Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2017 Jul; 140(1):170-176. PubMed ID: 27826093
[TBL] [Abstract][Full Text] [Related]
27. Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement.
Bernardo MM; Day DE; Olson ST; Shore JD
J Biol Chem; 1993 Jun; 268(17):12468-76. PubMed ID: 8509386
[TBL] [Abstract][Full Text] [Related]
28. Activation of the plasma kallikrein/kinin system on endothelial cell membranes.
Røjkjaer R; Schmaier AH
Immunopharmacology; 1999 Sep; 43(2-3):109-14. PubMed ID: 10596841
[TBL] [Abstract][Full Text] [Related]
29. Structural and functional characterization of factor XII.
Tans G; Rosing J
Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
[TBL] [Abstract][Full Text] [Related]
30. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
Front Immunol; 2018; 9():21. PubMed ID: 29467753
[TBL] [Abstract][Full Text] [Related]
31. A mosquito salivary protein inhibits activation of the plasma contact system by binding to factor XII and high molecular weight kininogen.
Isawa H; Yuda M; Orito Y; Chinzei Y
J Biol Chem; 2002 Aug; 277(31):27651-8. PubMed ID: 12011093
[TBL] [Abstract][Full Text] [Related]
32. Zinc-dependent contact system activation induces vascular leakage and hypotension in rodents.
Björkqvist J; Lecher B; Maas C; Renné T
Biol Chem; 2013 Sep; 394(9):1195-204. PubMed ID: 23640941
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
Veloso D; Silver LD; Hahn S; Colman RW
Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
[TBL] [Abstract][Full Text] [Related]
34. Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems.
Hardy LJ; Bohinc D; Bane KL; Heal SL; Hethershaw E; Ali M; Palmer-Dench T; Foster R; Longstaff C; Renné T; Stavrou EX; Philippou H
J Thromb Haemost; 2023 Apr; 21(4):814-827. PubMed ID: 36990522
[TBL] [Abstract][Full Text] [Related]
35. The bradykinin-forming cascade and its role in hereditary angioedema.
Kaplan AP; Joseph K
Ann Allergy Asthma Immunol; 2010 Mar; 104(3):193-204. PubMed ID: 20377108
[TBL] [Abstract][Full Text] [Related]
36. High affinity binding of factor XIIa to an electronegative surface controls the rates of factor XII and prekallikrein activation in vitro.
Mitropoulos KA
Thromb Res; 1999 Apr; 94(2):117-29. PubMed ID: 10230897
[TBL] [Abstract][Full Text] [Related]
37. Identification of Human Kinin-Forming Enzyme Inhibitors from Medicinal Herbs.
Madkhali H; Tarawneh A; Ali Z; Le HV; Cutler SJ; Khan IA; Shariat-Madar Z
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299400
[TBL] [Abstract][Full Text] [Related]
38. Aprotinin in cardiopulmonary bypass--effects on the Hageman factor (FXII)--Kallikrein system and blood loss.
Fuhrer G; Gallimore MJ; Heller W; Hoffmeister HE
Blood Coagul Fibrinolysis; 1992 Feb; 3(1):99-104. PubMed ID: 1377956
[TBL] [Abstract][Full Text] [Related]
39. Physiologic activities of the contact activation system.
Schmaier AH
Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
[TBL] [Abstract][Full Text] [Related]
40. Formation of bradykinin: a major contributor to the innate inflammatory response.
Joseph K; Kaplan AP
Adv Immunol; 2005; 86():159-208. PubMed ID: 15705422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
